Wordt geladen...
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of HIPEC, so full-dose utilization cannot be achieved. Herein, we sought to explore how much cisplatin is actually ut...
Bewaard in:
| Gepubliceerd in: | J Ovarian Res |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7796576/ https://ncbi.nlm.nih.gov/pubmed/33419462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-021-00764-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|